Cardiac biomarkers play a pivotal role in modern healthcare, providing valuable insights into the functioning of the heart and aiding in the diagnosis, prognosis, and monitoring of cardiovascular conditions. These biomarkers, often proteins released into the bloodstream in response to heart damage or stress, serve as crucial indicators for healthcare professionals. Troponins, creatine kinase-MB (CK-MB), and B-type natriuretic peptide (BNP) are among the well-known cardiac biomarkers. The detection and analysis of these biomarkers have significantly enhanced our ability to assess cardiac health, allowing for early intervention and personalized treatment strategies. As the field of cardiac biomarkers continues to evolve, ongoing research explores novel markers and advanced diagnostic technologies, promising further advancements in cardiovascular care. The comprehensive understanding of cardiac biomarkers contributes to more accurate diagnoses, improved patient outcomes, and a deeper comprehension of heart-related diseases.